Chapter
The Genetics of Aging and Longevity with Dr. David Sinclair
21:38 - 26:09 (04:30)
Dr. David Sinclair discusses the challenge in developing drugs for aging, as people live for a long time and it would take decades to know the efficacy of a drug. He instead turns to studying the genetics of dogs to better understand aging and longevity.
Clips
Despite the emergence of companies focused on understanding aging, none of them are actually working on developing drugs for aging, primarily because it takes decades to determine if a drug worked or not.
21:38 - 23:37 (01:59)
Summary
Despite the emergence of companies focused on understanding aging, none of them are actually working on developing drugs for aging, primarily because it takes decades to determine if a drug worked or not. They are examining the effects of aging instead of the aging process itself.
ChapterThe Genetics of Aging and Longevity with Dr. David Sinclair
EpisodeThis CEO Wants a Fountain of Youth for Dogs. Can We Be Next? Please?
PodcastThe Problem With Jon Stewart
The genetics that control dog size and lifespan are linked to one of the most well understood longevity pathways.
23:37 - 26:09 (02:31)
Summary
The genetics that control dog size and lifespan are linked to one of the most well understood longevity pathways. Larger dogs typically have a shorter lifespan due to their specific genes, rather than their overall size.